Flow cytometric analysis demonstrated that the S-AgNP-treated groups had considerably higher tumor-infiltrating CD8+ T cell activity (GZMB+ or IFN-γ+) (Fig. 5E). This evidence concerns the gene IFNG and neoplasm.